Please login to the form below

Not currently logged in
Email:
Password:

Foundation Medicine

This page shows the latest Foundation Medicine news and features for those working in and with pharma, biotech and healthcare.

Roche undercuts price of Bayer cancer drug after winning FDA approval

Roche undercuts price of Bayer cancer drug after winning FDA approval

In Japan, where Rozlytrek won approval earlier this year, the drug came to market in conjunction with a companion diagnostic developed by Roche-subsidiary Foundation Medicine. ... Roche is working with Foundation Medicine to prepare a filing for FDA

Latest news

More from news
Approximately 2 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    AstraZeneca is collaborating with numerous firms in this field, including Foundation Medicine, which specialises in next-generation gene sequencing technology.

  • Real-world evidence Real-world evidence

    Mental Health Foundation; London School of Hygiene &Tropical Medicine; RWE consultant.

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Corporate acquisition. 5, 200. Foundation Medicine/Roche. Broad R&D collaboration to optimise oncology treatments via Foundations genomic analysis and molecular information.

  • Pharma deals during January 2015 Pharma deals during January 2015

    First up was the acquisition of a majority interest in Foundation Medicine for a total of $1.18bn.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Biogen Idec appoints senior neuroscientists Biogen Idec appoints senior neuroscientists

    Dr Henderson was most recently Gurewitsch and Vidda Foundation professor of Rehabilitation and Regenerative Medicine at Columbia University in New York City. ... He was also professor of Molecular Medicine at the Lerner College of Medicine at Case

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    However, in precision medicine, we ask what treatment is best for the patient? ... This sets out a clear need for treatment agnostic broad panel testing that provides physicians with a decision support mechanism.  Foundation Medicine  has risen to this

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics